Brain and Mind Institute, Aga Khan University, Karachi, Pakistan.
Department of Community Health Sciences, Aga Khan University, Karachi, Pakistan.
JMIR Res Protoc. 2024 Jul 23;13:e54272. doi: 10.2196/54272.
There is a dearth of specialized mental health workforce in low- and middle-income countries. Use of mobile technology by frontline community health workers (CHWs) is gaining momentum in Pakistan and needs to be explored as an alternate strategy to improve mental well-being.
The aim of this study is to assess the feasibility, acceptability, and usefulness of an app-based counseling intervention delivered by government lady health workers (LHWs) to reduce anxiety and depression in rural Pakistan.
Project mPareshan is a single-arm, pre- and posttest implementation research trial in Badin District, Sindh, using mixed methods of data collection executed in 3 phases (preintervention, intervention, and postintervention). In the preintervention phase, formative qualitative assessments through focus group discussions and in-depth interviews assess the acceptability and appropriateness of intervention through perceptions of all concerned stakeholders using a specific interview guide. A REDCap (Research Electronic Data Capture)-based baseline survey using Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 Scale (GAD-7) determines the point prevalence of depression and anxiety among consenting men and women older than 18 years. Individuals with mild and moderate anxiety and depression are identified as screen positives (SPs) and are eligible for mPareshan app-based intervention. Mental health literacy of health workers is improved through customized training adapting the World Health Organization's Mental Health Gap Action Programme guide 2.0. The intervention (mPareshan app) consists of tracking, counseling, and referral segments. The tracking segment facilitates participant consent and enrollment while the referral segment is used by LHWs to transfer severe cases to the next level of specialist care. Through the counseling segment, identified SPs are engaged during LHWs' routine home visits in 6 face-to-face 20-minute counseling sessions over 6 months. Each session imparts psychoeducation through audiovisual aids, breathing exercises, and coping skills to reduce stress. Clinical and implementation outcomes include change in mean anxiety and depression scores and identification of facilitators and barriers in intervention uptake and rollout.
At the time of this submission (April 2024), we are analyzing the results of 366 individuals who participated in the baseline prevalence survey, the change in knowledge and skills of 72 health workers who took the mPareshan training, change in anxiety and depression scores of 98 SPs recruited for app-based counseling intervention, and perceptions of stakeholders pre- and postintervention gathered through 8 focus group discussions and 18 in-depth interviews.
This trial will assess the feasibility of early home-based mental health screening, counseling, and prompt referrals by frontline health workers to reduce anxiety and depression in the community. The study findings will set the stage for integrating mental health into primary health care.
Australian New Zealand Clinical Trial Registry ACTRN12622000989741; https://tinyurl.com/5n844c8z.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/54272.
在中低收入国家,精神卫生专业人员严重短缺。在巴基斯坦,前线社区卫生工作者(CHW)使用移动技术的做法正在兴起,需要将其作为改善精神健康的替代策略进行探索。
本研究旨在评估一种基于应用程序的咨询干预措施的可行性、可接受性和有用性,该措施由政府女卫生工作者(LHW)提供,以减少巴基斯坦农村地区的焦虑和抑郁。
项目 mPareshan 是在信德省巴丁区进行的一项单臂、预-后测试实施研究试验,采用混合方法收集数据,分为 3 个阶段(干预前、干预中和干预后)进行。在干预前阶段,通过焦点小组讨论和深入访谈进行的定性评估,使用特定的访谈指南,通过所有相关利益攸关方的看法,评估干预措施的可接受性和适当性。一项基于 REDCap(研究电子数据捕获)的基线调查使用患者健康问卷-9(PHQ-9)和广泛性焦虑障碍-7 量表(GAD-7),确定同意参加的 18 岁以上男性和女性中抑郁和焦虑的现患率。将轻度和中度焦虑和抑郁的个体确定为筛查阳性(SP),并符合 mPareshan 基于应用程序的干预条件。通过定制培训来提高卫生工作者的心理健康素养,培训改编自世界卫生组织的精神卫生差距行动规划指南 2.0。干预措施(mPareshan 应用程序)包括跟踪、咨询和转介部分。跟踪部分方便参与者同意和注册,而转介部分则由 LHW 用于将严重病例转介给下一级专科护理。通过咨询部分,在 LHW 进行常规家访期间,与 6 个月内的 6 次面对面的 20 分钟咨询中,与确定的 SP 进行互动。每次咨询都通过视听辅助、呼吸练习和应对技巧进行心理教育,以减轻压力。临床和实施结果包括焦虑和抑郁评分的均值变化,以及干预措施采用和推广过程中发现的促进因素和障碍。
截至提交(2024 年 4 月)时,我们正在分析参加基线患病率调查的 366 名参与者、接受 mPareshan 培训的 72 名卫生工作者的知识和技能变化、接受基于应用程序的咨询干预的 98 名 SP 的焦虑和抑郁评分变化,以及通过 8 个焦点小组讨论和 18 个深入访谈收集的利益相关者在干预前后的看法。
澳大利亚和新西兰临床试验注册 ACTRN12622000989741;https://tinyurl.com/5n844c8z。
国际注册报告标识符(IRRID):DERR1-10.2196/54272。